ETIVF yields 7535.80% · JNJ yields 2.13%● Live data
📍 ETIVF pulled ahead of the other in Year 1
Combined, ETIVF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ETIVF + JNJ for your $10,000?
Unbound Group plc, formerly known as Electra Private Equity PLC, specializes in growth capital, buyouts, recapitalization, control buyouts, PIPEs, middle market investments. It invests across all sectors and is not sector specific. The fund seeks to invest in companies based in the Continental Europe, United States and principally in Western Europe, with the majority of investments made in the United Kingdom. It typically invests between £40 million ($49.79 million) and £150 million ($180.73 million). It also co-invests £30 million ($37.35 million) to £100 million ($124.49 million) in minority positions in UK or International companies, alongside founders, other private equity firms, corporates or the public markets. It makes both minority and majority investments. The fund structures its investments through equity, senior equity, and convertible and mezzanine debt. It invests directly from its balance sheet.
Full ETIVF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.